---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-059841"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2023-05-12T23:59:59+00:00"
generated_at: "2026-06-15T02:32:07.425661+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Nasdaq notified Jaguar Health on May 10, 2023, that its stock's bid price closed below $1.00 for 30 consecutive business days, violating Listing Rule 5550(a)(2).
- Company granted 180-day grace period until November 6, 2023, to regain compliance by achieving closing bid price of at least $1.00 for 10 consecutive business days.
- If not compliant by Nov 6, Nasdaq may grant a second 180-day period if the company meets other initial listing standards, including stockholders' equity of at least $5 million (current condition).
- Jaguar Health states it is diligently working to evidence compliance but cannot assure regaining compliance or extension.

## SEC filing metadata
- accession: 0001104659-23-059841
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2023-05-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000110465923059841/0001104659-23-059841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000110465923059841/tm2315450d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-059841
- JSON: https://secwatch.observer/filing/0001104659-23-059841.json
- Plain text: https://secwatch.observer/filing/0001104659-23-059841.txt

## Key facts
- Listing & Compliance Notices
  Jaguar Health, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: May 10, 2023, Jaguar Health, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the bid price for the Company’s common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Nasdaq Listing Rule 5550(a)(2). Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180 calendar day grace period, or until November 6, 2023, to regain compliance with the minimum bid price requirement. The continued listing standard
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000110465923059841/0001104659-23-059841-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.